Soterius for Breast Cancer
Breast Cancer
October is the breast cancer awareness month, a worldwide campaign to educate and support awareness about breast cancer and the importance of its early detection.
Breast cancer is by far the most common cancer affecting about 1.38 million women and claiming 458,000 lives each year. Like most cancers, there is not enough evidence leading us to the cause of Breast Cancer, which makes early detection the cornerstone to improve the chances of the treatment.
Soterius recognizes the importance of breast cancer awareness and advocates Early Diagnosis, Mammography Screening and Clinical Breast Examination for better outcomes and survival rate.
You can donate to National Breast Cancer Foundation by clicking here. National Breast Cancer Foundation works to provide help and inspire those affected by breast cancer through early detection, education, and support services.
Disclaimer
Copyright 2025 by Soterius, Inc. All rights reserved. Soterius logo are trademarks or registered trademarks of Soterius in all jurisdictions. Other marks may be trademarks or registered trademarks of their respective owners. The information you see, hear or read on the pages within this presentation, as well as the presentation’s form and substance, are subject to copyright protection. In no event, may you use, distribute, copy, reproduce, modify, distort, or transmit the information or any of its elements, such as text, images or concepts, without the prior written permission of Soterius. No license or right pertaining to any of these trademarks shall be granted without the written permission of Soterius (and any of its global offices and/or affiliates). Soterius reserves the right to legally enforce any infringement of its intellectual property, copyright and trademark rights. Any content presented herewith should only be considered for general informational purposes and should not be considered as specific to the requirements of any particular organisation or for any specific purpose. Soterius does not make any representations or warranties about the completeness, reliability, appropriateness, relevance, or accuracy of the content presented here.
Discover more
admin •
10 Min Read
Postmarketing Adverse Drug Experience (PADE) Inspections – Part I
Legal Framework of PADE Inspections PADE Statutory Provisions / Regulations: Prescription Drug Products for Human Use S.no FD&C Act, subchapter V, part A, section 505 (21 U.S.C. 355) Comments…
admin •
10 Min Read
Audits in Pharmacovigilance: A commitment to Safety
In the realm of healthcare, ensuring patient safety is the most important aspect. That’s where pharmacovigilance plays a role in safeguarding lives by monitoring the safety of medicinal products. But…
admin •
10 Min Read
Causality Assessment in Pharmacovigilance
The causality assessment of adverse events, to determine the relationship or connection between the drug and adverse events, is an essential and complex approach in pharmacovigilance. The recognition of a…